FindTrial
Sign In

Standard-of-care treatment

DRUG7 trials

Sponsors

Josko Bozic, Second Affiliated Hospital, School of Medicine, Zhejiang University, Janssen Research & Development, LLC, Karolinska University Hospital, Purdue University

Conditions

Covid-19DysphagiaHeart Failure，CongestiveLupus NephritisParkinson DiseasePeripheral Vascular Disorder Due to Diabetes MellitusStrokeSystemic Lupus Erythematosus

Phase 2

A Study of Guselkumab in Participants With Active Lupus Nephritis
TerminatedNCT04376827
Janssen Research & Development, LLCLupus Nephritis
Start: 2020-09-15End: 2023-02-01Updated: 2025-03-30
A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study
NCT04412291
Karolinska University HospitalCovid-19
Start: 2020-06-11End: 2021-06-30Target: 120Updated: 2021-02-18
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus
CompletedNCT04882878
Janssen Research & Development, LLCSystemic Lupus Erythematosus
Start: 2021-08-20End: 2024-12-26Updated: 2025-12-08
A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
WithdrawnNCT04883619
Janssen Research & Development, LLCLupus Nephritis
Start: 2026-01-15End: 2028-02-28Updated: 2026-02-27
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
RecruitingNCT06638944
Purdue UniversityDysphagia, Parkinson Disease, Stroke
Start: 2025-07-22End: 2029-04-30Target: 120Updated: 2026-01-12

Phase 4

Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
NCT04146155
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPeripheral Vascular Disorder Due to Diabetes Mellitus, Type 2 Diabetes
Start: 2020-05-01End: 2021-12-31Target: 200Updated: 2021-07-07

Unknown Phase

Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure
CompletedNCT03389386
Josko BozicHeart Failure，Congestive
Start: 2018-01-25End: 2019-04-16Updated: 2019-04-17

Related Papers

Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study
Lara D. Veeken2024-12-024 citations
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial
PLoS ONE2023-12-298 citations
LP-195 Design of a Phase 2 study evaluating the efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus
2023-07-011 citations
Pleiotropic effects of GLP‐1 receptor agonists on peripheral artery disease: Is there any hope?
Diabetes/Metabolism Research and Reviews2023-02-2212 citations
611 Efficacy and safety of nipocalimab in adult patients with active systemic lupus erythematosus: design of a phase 2 study
2022-12-01
PO.6.137 Design of a phase 2, multicenter, randomized, placebo-controlled, parallel-group, double-blind study to assess the efficacy and safety of nipocalimab in adults with active systemic lupus erythematosus
2022-09-27
Circulating sST2 and Catestatin Levels in Patients with Acute Worsening of Heart Failure: A Report from the CATSTAT-HF Study
ESC Heart Failure2020-07-1825 citations
Right Ventricular Free Wall Strain and Congestive Hepatopathy in Patients with Acute Worsening of Chronic Heart Failure: A CATSTAT-HF Echo Substudy
Journal of Clinical Medicine2020-05-0217 citations
Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study
Journal of Clinical Medicine2019-07-3035 citations